A sample drawn by the previous supplier of a Hep C study conducted for a large pharmaceutical company in the US was made up of only 14% non-Caucasians. According to the CDC, non-Caucasians made up 35%of the Hep C cases of chronic HCV in the US in 2000. Thus, the previous supplier’s study was drawn from an incorrect sample.
Both of our subsequent studies were composed of a representative sample that included the correct proportions.
Hep C Study Shows Why Sampling Matters
Our respondents mirrored actual US patient universe